Variable | Dose | |||
---|---|---|---|---|
Unvaccinated | 1 | 2+ | Unknown | |
Age(years) | ||||
< 1 | 140 (47.5%) | 121 (41.0%) | 24 (8.1%) | 10 (3.4%) |
1–4 | 32 (7.5%) | 155 (36.1%) | 216 (50.3%) | 26 (6.1%) |
5–14 | 163 (13.5%) | 480 (39.9%) | 292 (24.3%) | 269 (22.3%) |
≥ 15 | 63 (30.9%) | 28 (13.7%) | 3 (1.5%) | 110 (53.9%) |
Sex | ||||
Female | 196 (18.3%) | 384 (35.9%) | 269 (25.1%) | 222 (20.7%) |
Male | 202 (19.0%) | 400 (37.7%) | 266 (25.1%) | 193 (18.2%) |
Treatment modality | ||||
Inpatient | 78 (22.6%) | 136 (39.4%) | 68 (19.7%) | 63 (18.3%) |
Outpatient | 320 (17.9%) | 648 (36.3%) | 467 (26.1%) | 352 (19.7%) |
Total | 398 (18.7%) | 784 (36.8%) | 535 (25.1%) | 415 (19.5%) |